Literature DB >> 11591741

Peptide length variants p2Ca and QL9 present distinct conformations to L(d)-specific T cells.

T M Hornell1, S M Martin, N B Myers, J M Connolly.   

Abstract

Recent advances have provided insights into how the TCR interacts with MHC/peptide complexes and a rationale to predict optimal epitopes for MHC binding and T cell recognition. For example, peptides of nine residues are predicted to be optimal for binding to H2-L(d), although 8 mer epitopes have also been identified. It has been predicted that 8 mer and 9 mer length variant peptides bound to L(d) present identical epitopes to T cells. However, in contrast to this prediction, we demonstrate here that the 8 mer peptide p2Ca and its 9 mer length variant QL9, extended by an N-terminal glutamine, assume distinct conformations when bound to L(d). We generated self-L(d)-restricted CTL clones specific for p2Ca that recognize L(d)/QL9 poorly if at all. This result is in sharp contrast to what has been observed with L(d)-alloreactive T cells that possess a much higher affinity for L(d)/QL9 than for L(d)/p2Ca. Alanine substitutions of the N-terminal residues of the QL9 peptide rescue detection by these self-L(d)/p2Ca-specific T cells, but decrease recognition by the L(d)-alloreactive 2C T cell clone. In addition, 2C T cell recognition of the p2Ca peptide is affected by different alanine substitutions compared with 2C T cell recognition of the QL9 peptide. These data clearly demonstrate that the p2Ca and QL9 peptides assume distinct conformations when bound to L(d) and, furthermore, demonstrate that there is flexibility in peptide binding within the MHC class I cleft.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591741     DOI: 10.4049/jimmunol.167.8.4207

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.

Authors:  Susan E Brophy; Lindsay L Jones; Phillip D Holler; David M Kranz
Journal:  Mol Immunol       Date:  2006-12-12       Impact factor: 4.407

2.  The effect of mutations on the alloreactive T cell receptor/peptide-MHC interface structure: a molecular dynamics study.

Authors:  Mikhail Y Wolfson; Kwangho Nam; Arup K Chakraborty
Journal:  J Phys Chem B       Date:  2011-06-09       Impact factor: 2.991

3.  Embryonic stem cell-derived haematopoietic progenitor cells down-regulate the CD3 ξ chain on T cells, abrogating alloreactive T cells.

Authors:  Eun-Mi Kim; Bob Miyake; Manish Aggarwal; Ruth Voetlause; Maia Griffith; Nicholas Zavazava
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

4.  Different strategies adopted by K(b) and L(d) to generate T cell specificity directed against their respective bound peptides.

Authors:  Natalie A Bowerman; Leremy A Colf; K Christopher Garcia; David M Kranz
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

5.  Potentiation of T Cell Stimulatory Activity by Chemical Fixation of a Weak Peptide-MHC Complex.

Authors:  Inkyu Hwang; Kwangmi Kim; Sojin Choi; Maria Lomunova
Journal:  Mol Cells       Date:  2017-01-31       Impact factor: 5.034

6.  Molecular analysis of thymopentin binding to HLA-DR molecules.

Authors:  Zuojia Liu; Xiliang Zheng; Jin Wang; Erkang Wang
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.